Longitudinal Audiological and Vestibular Follow-up in Adult Cancer Patients Receiving Platinum-Based Chemotherapy

Platinum-based chemotherapy is widely used in cancer care but carries a substantial risk of cochleotoxicity and vestibulotoxicity. This study aimed to characterize early (3-month) and long-term (1-year) auditory and vestibular effects of platinum derivatives in adults, with the goal of improving monitoring strategies.

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

Audiologists working with oncology teams should consider structured longitudinal monitoring of both hearing and vestibular function in patients on platinum-based chemotherapy, as early detection of toxicity may allow treatment modification; this study reinforces — and may refine — existing ototoxicity monitoring guidelines.

✦ Why It Matters ✦

Platinum-based chemotherapy is widely used and its ototoxic and vestibulotoxic side effects are a significant survivorship concern; longitudinal data characterizing the timeline of these toxicities can directly improve monitoring protocols and quality of life for cancer survivors.

✦ Key Points ✦

01Longitudinal study tracks both hearing loss (cochleotoxicity) and balance dysfunction (vestibulotoxicity) in adult cancer patients on platinum chemotherapy.
02Published in JARO (Journal of the Association for Research in Otolaryngology), a leading audiology/otology research journal.
03Early audiological and vestibular changes were characterized over serial follow-up assessments.
04Findings are relevant to developing or updating ototoxicity monitoring protocols in oncology settings.
05Both cochlear and vestibular toxicity pathways were assessed, providing a more complete picture of platinum drug side effects.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Platinum-based chemotherapy causes early cochleotoxicity and vestibulotoxicity detectable through longitudinal audiological and vestibular assessments.

studysupported

Serial audiological and vestibular follow-up can characterize the timeline of platinum-induced toxicity in adult cancer patients.

studysupported

✦ Research metadata ✦

PMID: 42443713
DOI: 10.1007/s10162-026-01062-y.
Journal: Journal of the Association for Research in Otolaryngology
Publication type: research_article
Evidence level: 2b
Population: Adult cancer patients receiving platinum-based chemotherapy
Intervention: Platinum-based chemotherapy with longitudinal audiological and vestibular monitoring

Primary outcomes

Early cochleotoxicity detection via audiological assessment; Vestibulotoxicity characterization via vestibular function testing

✦ Related stories ✦

PubMed·Clinical trial·Clinical audiology·2w ago

Hearing Intervention for Older Adults With Mild Cognitive Impairment: The CHOICE Randomized Clinical Trial

Await full published results before changing practice; this RCT directly tests whether hearing intervention stabilizes cognition in MCI, making it highly relevant, but actionability depends on the magnitude and direction of outcomes not yet fully available in this summary.

PubMed·Journal article·Clinical audiology·2w ago

Effect of selected components of aural rehabilitation delivered in-person versus guided internet-based modalities on quality of life in adults with hearing loss: a systematic review and meta-analyses

Clinicians can consider offering guided internet-based aural rehabilitation as a quality-of-life intervention for adults with hearing loss; the systematic review provides moderate-to-strong evidence that digital delivery is a viable alternative to in-person care, though effect...

PubMed·Journal article·Clinical audiology·5mo ago

Functional Benefits of Bilateral Bone Conduction Hearing Devices for Children and Adults With Conductive and Mixed Hearing Losses

Findings may support recommending bilateral (two-device) bone conduction fittings over unilateral for eligible patients with conductive or mixed hearing loss, but full results should be reviewed before changing fitting protocols.

PubMed·Journal article·Clinical audiology·3mo ago

Audiologic Assessment and Management of Teprotumumab-Associated Ototoxicity: An Updated Narrative Review

Audiologists should implement proactive baseline and monitoring audiologic assessments for patients prescribed teprotumumab, as ototoxicity risk is well-documented; this review provides updated clinical guidance on assessment and management strategies.

PubMed·Journal article·Clinical audiology·3mo ago

Development of a Visual Faces Scale for Adults with Hearing Loss: The Facial Scale of Hearing Difficulty

Consider evaluating the Facial Scale of Hearing Difficulty as a quick screening tool in busy clinic settings, particularly for patients who may struggle with traditional written questionnaires; however, await broader validation studies before replacing established tools.

PubMed·Journal article·Clinical audiology·4mo ago

Sudden Hearing Loss in Enlarged Vestibular Aqueduct Syndrome: A Systematic Review of Treatment and Outcomes

Audiologists and otolaryngologists managing patients with EVA and sudden hearing loss should note this review's synthesis of treatment outcomes, though the evidence base is likely limited by small, heterogeneous studies; current treatment decisions should be made in consultation...

PubMed·Journal article·Clinical audiology·2mo ago

Beyond steroid monotherapy: a systematic review and meta-analysis of combination therapy for severe to profound sudden sensorineural hearing loss

Audiologists and ENTs managing severe-to-profound sudden sensorineural hearing loss should be aware that this meta-analysis supports combination systemic plus intratympanic corticosteroid therapy over systemic steroids alone — referral pathways and counselling for at-risk...

PubMed·Journal article·Clinical audiology·2mo ago

Conventional Reporting Standards Conceal High-Frequency Hearing Deficits After Favorable Ossiculoplasty

Audiologists and surgeons should consider adding high-frequency pure-tone testing to routine post-ossiculoplasty outcome reporting, as standard four-frequency averages may mask clinically meaningful high-frequency deficits.